Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery

American Heart Journal

Volumn 160, Issue 2, 2010, Pages 362-369

  Selleng, Sixten ^a   Malowsky, Birgit ^b   Itterman, Till ^a   Bagemühl, Jessica ^a   Wessel, Antje ^a   Wollert, Hans Georg ^b   Warkentin, Theodore E ^c   Greinacher, Andreas ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b Herz und Diabeteszentrum Mecklenburg/Vorpommern   (Germany)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ARTERY THROMBOSIS; ARTICLE; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CARDIOVASCULAR PARAMETERS; DEEP VEIN THROMBOSIS; FEMALE; HAZARD RATIO; HEART INFARCTION; HEMORRHAGIC SHOCK; HOSPITALIZATION; HUMAN; IMMUNOASSAY; KIDNEY FAILURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE; RISK FACTOR; STROKE; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; CARDIAC SURGICAL PROCEDURES; FEMALE; HEPARIN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; PLATELET FACTOR 4; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 77955464540     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.05.026     Document Type: Article

References (26)

1. Bauer T.L., Arepally G., and Konkle B.A. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery Circulation 95 1997 1242 1246
2. Bennett-Guerrero E., Slaughter T.F., and White W.D. Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery J Thorac Cardiovasc Surg 130 2005 1567 1572
3. Everett B.M., Yeh R., and Foo S.Y. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery Ann Thorac Surg 83 2007 592 597
4. Gluckman T.J., Segal J.B., and Schulman S.P. Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery J Thromb Haemost 7 2009 1457 1464
5. Mattioli A.V., Bonetti L., and Zennaro M. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up Am Heart J 157 2009 589 595
6. Kress D.C., Aronson S., and McDonald M.L. Positive heparin-platelet factor 4 antibody complex and cardiac surgical outcomes Ann Thorac Surg 83 2007 1737 1743
7. Greinacher A., Juhl D., and Strobel U. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes J Thromb Haemost 5 2007 1666 1673
8. Warkentin T.E., Sheppard J.A., and Moore J.C. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? J Lab Clin Med 146 2005 341 346
9. Paparella D., Scrascia G., and Galeone A. Formation of anti-platelet factor 4/heparin antibodies after cardiac surgery: influence of perioperative platelet activation, the inflammatory response, and histocompatibility leukocyte antigen status J Thorac Cardiovasc Surg 136 2008 1456 1463
10. Selleng S., Malowsky B., and Strobel U. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia even when antibody tests are positive J Thromb Haemost 8 2010 30 36
11. Nashef S.A., Roques F., and Michel P. European system for cardiac operative risk evaluation (EuroSCORE) Eur J Cardiothorac Surg 16 1999 9 13
12. Pouplard C., May M.A., and Regina S. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies Br J Haematol 128 2005 837 841
13. Juhl D., Eichler P., and Lubenow N. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia Eur J Haematol 76 2006 420 426
14. Greinacher A., Michels I., and Kiefel V. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia Thromb Haemost 66 1991 734 736
15. Schenk S., El Banayosy A., and Morshuis M. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support J Thromb Haemost 5 2007 235 241
16. Whitlatch N.L., Perry S.L., and Ortel T.L. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia Thromb Haemost 100 2008 678 684
17. Savi P., Chong B.H., and Greinacher A. Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin Blood 105 2005 139 144
18. Warkentin T.E., and Kelton J.G. Temporal aspects of heparin-induced thrombocytopenia N Engl J Med 344 2001 1286 1292
19. Denomme G.A., Warkentin T.E., and Horsewood P. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia J Lab Clin Med 130 1997 278 284
20. Rauova L., Zhai L., and Kowalska M.A. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications Blood 107 2006 2346 2353
21. Kelton J.G., Sheridan D., and Santos A. Heparin-induced thrombocytopenia: laboratory studies Blood 72 1988 925 930
22. Warkentin T.E., Greinacher A., and Koster A. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 340S 380S
23. Dyke C.M., Smedira N.G., and Koster A. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study J Thorac Cardiovasc Surg 131 2006 533 539
24. Koster A., Dyke C.M., and Aldea G. Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial Ann Thorac Surg 83 2007 572 577
25. Pötzsch B., Klovekorn W.P., and Madlener K. Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia N Engl J Med 343 2000 515
26. Selleng S., Haneya A., and Hirt S. Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantation Blood 112 2008 4024 4027